Press launch MHRA approves GLP –one receptor agonist semaglutide to lessen hazard of significant heart challenges in obese or overweight adults Semaglutide is the first weight-loss drug accepted in the UK being a preventative cure for all those with proven cardiovascular diseaseMake sure you Stick to the tracking facts provided by Evri to ensure … Read More